August 22nd 2025
New support offers a streamlined experience for surgeons and patients
Retropupillary implantation of iris-claw lenses
September 1st 2007There are several surgical options available for the correction of aphakia, yet there is no clear winner in the competition for the best method: anterior chamber intraocular lenses (IOLs), suturing a posterior chamber IOL in the sulcus or using an iris claw lens. If an iris-claw lens, like the Verisyse IOL (AMO), is chosen, it will usually be fixated to the iris in the anterior chamber. Alternatively this IOL can also be fixated on the posterior surface of the iris (Figure 1).
Aberropia: the discovery of a new refractive entity
July 1st 2007Prior to the advent of wavefront-guided LASIK, the only parameters that could be modified in order to obtain optical correction for a given patient's refractive error were the sphere, cylinder and axis. This approach, however, would often not yield the ideal optical correction and, in many cases, the post-refractive surgery patient may be able to read the 20/20 line but not clearly. In some cases, best corrected visual acuity (BCVA) would even decrease following surgery. This situation can usually be attributed to the persistence of significant amounts of higher order aberrations (HOAs).
Refractive enhancements: making the patient happy second time round
July 1st 2007The quest for safe, effective surgery, which produces optimal results, has prompted much debate among experts on what the best procedure is for performing laser enhancements. For wavefront-guided enhancements, lamellar and surface procedures are both popular methods and I would like to discuss my experience and share my thoughts on their future in refractive surgery.
Investigational phakic IOL: examining the evidence
June 1st 2007The AcrySof angle-supported phakic refractive IOL (Alcon) continues to offer patients with high myopia stable and accurate refractive results with excellent visual acuity (VA), according to physicians speaking at the XXIV Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) in London last September.
Vivarte IOL: good refractive results but withdrawn over safety concerns
June 1st 2007Correction of very high myopia, i.e. above –9.00 D, remains a controversial topic and new designs of phakic IOLs have spurred great interest in the past five years. Presently, long-term results are becoming available and some interesting conclusions can be drawn, explained Matteo Piovella, MD, who reported his four-year results with one of these lenses at the XXIV Congress of the European Society of Cataract and Refractive Surgeons in London.
Refractive surgery market to reach $4.5 billion by 2009
April 30th 2007The growing popularity of LASIK and other new innovations in refractive surgery is set to push sales in the global market from $1.3 billion in 2006 to an estimated $4.5 billion in 2009, according to market research firm Kalorama Information.
Preserved triamcinolone more likely to cause non-infectious endophthalmitis
April 30th 2007Non-infectious endophthalmitis is observed more frequently after injections of triamcinolone acetonide that contain preservatives (PTA) than after injections of preservative-free triamcinolone acetonide (PFTA), according to a study published online ahead of print in the British Journal of Ophthalmology.
Myopia could be mistaken for glaucoma in some
April 30th 2007A study published in the March issue of Ophthalmology, has found that many young and middle-aged people of Chinese ancestry who are told they have glaucoma may actually be misdiagnosed. These patients who do not show disease progression may, in fact, have glaucoma-like symptoms caused by myopia.